Celldex Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Celldex Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Celldex Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.45M, a 24.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.45M -$806K -24.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.17M -$1.47M -40.4% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $2.58M -$1.42M -35.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.86M -$716K -20% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.26M -$688K -17.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.63M +$1.07M +41.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4M +$1.03M +34.7% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $3.58M +$564K +18.7% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.94M +$1.23M +45.1% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.56M -$524K -17% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.97M -$479K -13.9% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.02M -$785K -20.7% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.72M -$416K -13.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $3.09M -$651K -17.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.45M -$24K -0.69% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.8M +$370K +10.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.13M -$840K -21.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.74M -$706K -15.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $3.47M Dec 31, 2019 10-K 2021-03-29
Q3 2019 $3.43M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $3.97M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $4.45M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.